Raising the bar for hyper-personalised omnichannel experiences in healthcare
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
Discover what the latest global media trends reveal about the future of healthcare communication. From the shift to video content to the rise of new digital platforms, learn how these insights can help pharma engage more effectively with patients and healthcare professionals.
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
“Is AI good enough to create the content I need?”
I’m often asked this question when I meet marketing professionals in the pharma industry who are eager to harness the power of artificial intelligence in their operations. But we need to frame the question differently to get a meaningful answer: “In the era of generative AI, who decides what good content is?” If you approach the question from this perspective, you start to understand that AI is one part of a workflow and process, not the beginning and end of content production. Instead, it will augment human content creation, with humans making the key decisions about creative direction, quality, and compliance. The intelligent use of AI is very much a human endeavour. However, the need for augmenting human effort is beyond doubt.
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
The quest for ‘wow’ in content creation often overshadows the need for meaningful substance, particularly in pharma and healthcare. Sabine Louët, Founder of SciencePOD, highlights the dilemma facing marketers: achieving a ‘wow’ factor that attracts attention while ensuring the content remains credible, relevant, and clear. The article delves into how healthcare professionals (HCPs) prioritise content that is not only attention-grabbing but also trustworthy and scientifically robust.
Interview with Martin Møller, Global Director Omnichannel & CX Excellence, Novo Nordisk Martin Møller is the Global Director of Omnichannel & CX Excellence at Novo Nordisk. He is scheduled to speak at the Pharma Omnichannel HCP Engagement Conference, 23-24 May 2024, in Lisbon, at a session titled ‘Omnichannel Engagement Track: The HCP Portal as the …
Omnichannel, data, and the HCP portal experience Read More »
In an exclusive interview with SciencePOD, Sarah Christensen of Novartis unveils the future of HCP engagement through data-driven, personalised communication and cutting-edge AI technologies, ahead of her panel at Reuters Events: Pharma 2024.
Interview with Laëtitia Bouérat Duvold, Senior Director & Head of Global Medical Affairs Excellence, Lundbeck Laëtitia Bouérat Duvold, Senior Director & Head of Global Medical Affairs Excellence at Lundbeck, is scheduled to speak at the NEXT Pharma Summit in Dubrovnik, 14-15 May 2024 in a session entitled “Medical engagement and its place in Omnichannel. How …
Overcoming siloed thinking on the journey to omnichannel engagement Read More »
Join us for an exclusive interview with Donatello Crocetta, SVP at UCB, as he shares insights into innovative customer-facing roles and digital advancements in healthcare ahead of his panel at Reuters Events Pharma 2024.